Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Measurable residual FLT3 tyrosine kinase domain mutations before allogeneic transplant for acute myeloid leukemia ; day:18 ; month:10 ; year:2024 ; pages:1-3
Bone marrow transplantation ; (18.10.2024), 1-3
- Urheber
-
Hegde, Pranay S.
Andrew, Georgia
Gui, Gege
Ravindra, Niveditha
Mukherjee, Devdeep
Wong, Zoë C.
Auletta, Jeffery J.
El Chaer, Firas
Corner, Adam
Devine, Steven M.
Jimenez Jimenez, Antonio Martin
Lima, Marcos J. G. De
Litzow, Mark R.
Kebriaei, Partow
Saber, Wael
Spellman, Stephen R.
Zeger, Scott L.
Page, Kristin M.
Dillon, Laura W.
Hourigan, Christopher S.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41409-024-02444-7
- URN
-
urn:nbn:de:101:1-2501072129414.772678825830
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:24 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hegde, Pranay S.
- Andrew, Georgia
- Gui, Gege
- Ravindra, Niveditha
- Mukherjee, Devdeep
- Wong, Zoë C.
- Auletta, Jeffery J.
- El Chaer, Firas
- Corner, Adam
- Devine, Steven M.
- Jimenez Jimenez, Antonio Martin
- Lima, Marcos J. G. De
- Litzow, Mark R.
- Kebriaei, Partow
- Saber, Wael
- Spellman, Stephen R.
- Zeger, Scott L.
- Page, Kristin M.
- Dillon, Laura W.
- Hourigan, Christopher S.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurina
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
"Measurable distance"
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurina
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
"Measurable distance"
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice
FLT3-inhibitor therapy for prevention and treatment of relapse after allogeneic hematopoietic cell transplantation
Measurable residual mutated IDH2 before allogeneic transplant for acute myeloid leukemia
Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
Pre-transplant FLT3/ITD status predicts outcome in FLT3-mutated acute myeloid leukemia following allogeneic stem cell transplantation
Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia
Identification of Protein Tyrosine Phosphatases regulating FLT3 activity and of PTPs regulated by FLT3 ITD
Measurable residual disease monitoring in AML with FLT3-ITD treated with intensive chemotherapy plus midostaurina
Monitoring of measurable residual disease using circulating DNA after allogeneic hematopoietic cell transplantation
Receptor protein-tyrosine phosphatases controlling activity of the oncoprotein FLT3 ITD
"Measurable distance"
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease
Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice